MUC1 and pancreatic neoplasm: Previous research has shown that the cytoplasmic tail of MUC1 physically interacts with and blocks the proteasomal degradation of HIF-1α in pancreatic cancer cell lines and animal models, and higher expression of MUC1 was observed in gemcitabine-resistant cells [51].